Cover Image
市場調查報告書

經腸營養製劑市場預測:各產品類型 (標準製劑,疾病專一製劑),各用途,各地區

Enteral Feeding Formula Market: By Product Type (Standard Formula & Disease Specific Formulas); By Application (Oncology, Gastroenterology, Neurology, Critical Care & Others); & By Region-Forecast (2017-2022)

出版商 IndustryARC 商品編碼 422170
出版日期 內容資訊 英文 156 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
經腸營養製劑市場預測:各產品類型 (標準製劑,疾病專一製劑),各用途,各地區 Enteral Feeding Formula Market: By Product Type (Standard Formula & Disease Specific Formulas); By Application (Oncology, Gastroenterology, Neurology, Critical Care & Others); & By Region-Forecast (2017-2022)
出版日期: 2017年08月21日 內容資訊: 英文 156 Pages
簡介

本報告提供全球經腸營養製劑市場相關調查分析,提供市場形勢,市場動態,策略性分析,市場分析 (各市場區隔),再加上主要企業等相關的系統性資訊。

第1章 經腸營養製劑:市場概要

第2章 摘要整理

第3章 經腸營養製劑:市場形勢

  • 市場佔有率分析
  • 比較分析

第4章 經腸營養製劑:市場動態

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題
  • 波特的五力分析

第5章 經腸營養製劑市場:策略性分析

  • 價值鏈分析
  • 價格分析
  • 機會分析
  • 產品/市場生命週期分析
  • 供給業者·經銷商

第6章 經腸營養製劑市場:各產品類型

  • 標準製劑
  • 疾病專用特殊製劑

第7章 經腸營養製劑市場:各治療領域

  • 腫瘤
  • 消化器官
  • 神經
  • 重症加護診療
  • 其他

第8章 經腸營養製劑市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第9章 市場熵

第10章 企業簡介

  • Abbott Laboratories
  • Nestle S.A.
  • Danone
  • Fresenius Kabi
  • Mead Johnson Nutrition Company
  • B.Braun
  • Victius Inc.
  • 明治集團
  • Global Health Product Inc.
  • Merck & Co., Inc.

第11章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Enteral feeding or tube feeding formulas is a dietary preparation delivering a nutritionally complete food with carbohydrate, protein, fat, water, minerals and vitamins, directly into the stomach, duodenum or jejunum when a patient cannot swallow food orally. Enteral feeding formulas are segmented into standard and disease-specific formulas. The standard formulas segment is further sub-divided into polymeric, monomeric formulas and specialized formulas. The disease-specific formulas are divided into pulmonary, diabetic, hepatic, renal and others (immune-enhancing, wound-healing and critical care).

Monomeric formulas contain a single nutrient, such as proteins, fats, or carbohydrates. It may be used alone to treat a specific deficiency or jointly with other formulas to completely suit nutritional requirements. Polymeric formulas include food and milk-based or lactose-free formulas and it is considered as balanced diet. Specialized formulas are expensive and contain hydrolyzed protein or sometimes amino acid formulas, which are generally used for patients with difficulty in digesting complex proteins.

The increasing prevalence of chronic diseases and preterm births, rapidly growing ageing population and increasing demand for homecare services, drive the market of enteral feeding formulas.

This report provides information on enteral feeding formulas market size for the year 2014-2016, and forecast of the same for year 2021. It also focuses on market drivers, challenges, restraints, market dynamics, growth indicators, competitive landscape, potential growth opportunities and other key aspects with respect to enteral feeding formulas market.

North America and Europe have major share in global enteral feeding formula market followed by Asia-Pacific and ROW. North America and Europe are the major markets with growing geriatric population and chronic diseases. Asia-Pacific markets are driven by increased prevalence of chronic diseases, rising healthcare spending and population in APAC countries.

This report identifies global enteral feeding formulas market on the basis of product type, therapeutic area and regional market as follows:

Enteral feeding formulas market based on product type is segmented into standard and disease-specific formulas

Based on therapeutic area gastroenterology, neurology, critical care and others

This report is further segmented based on regional potential markets for enteral feeding formulas. A detailed analysis by region - North America, Europe, Asia-Pacific (APAC) and Rest of the World (ROW), has been provided in this report

This report looks into all the major companies operating in the enteral feeding formula market. Some of the major companies' profiles are as follows:

Abbott Laboratories

Nestle S.A

Danone S.A

Fresenius Kabi AG

Mead Johnson Nutrition Company

1. Enteral Feeding Formula - Market Overview

2. Executive Summary

3. Enteral Feeding Formula - Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. End User Profiling
    • 3.2.3. Top 5 Financials Analysis

4. Enteral Feeding Formula - Market Forces

  • 4.1. Drivers
    • 4.1.1. Rising prevalence of chronic diseases
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Force Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Customers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Enteral Feeding Formula Market - Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Enteral Feeding Formula Market, By Product type

  • 6.1. Standard formula
  • 6.2. Disease specific formulas

7. Enteral Feeding Formula Market, By Therapeutic area

  • 7.1. Oncology
  • 7.2. Gastroenterology
  • 7.3. Neurology
  • 7.4. Critical care
  • 7.5. Others

8. Enteral Feeding Formula Market, By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. US
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. Europe
    • 8.3.1. U.K
    • 8.3.2. France
    • 8.3.3. Germany
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe
  • 8.4. Asia Pacific
    • 8.4.1. China
    • 8.4.2. South Korea
    • 8.4.3. Japan
    • 8.4.4. India
    • 8.4.5. Rest of Asia Pacific
  • 8.5. RoW

9. Market Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply - Contract

10. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)

  • 10.1. Abbott Laboratories
  • 10.2. Nestle S.A.
  • 10.3. Danone
  • 10.4. Fresenius Kabi
  • 10.5. Mead Johnson Nutrition Company
  • 10.6. B.Braun
  • 10.7. Victius Inc.
  • 10.8. Meiji Holdings Co., Ltd.
  • 10.9. Global Health Product Inc.
  • 10.10. Merck & Co., Inc.

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Expert Insights
Back to Top